Total Payments
$298,707
2024 Payments
$108,914
Companies
37
Transactions
866
Medicare Patients
5,226
Medicare Billing
$1.4M
Payment Breakdown by Category
Other$199,676 (66.8%)
Consulting$60,951 (20.4%)
Food & Beverage$19,094 (6.4%)
Travel$18,446 (6.2%)
Education$513.60 (0.2%)
Gifts$26.70 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $143,510 | 53 | 48.0% |
| Consulting Fee | $60,951 | 18 | 20.4% |
| Compensation for serving as faculty or as a speaker for a medical education program | $53,713 | 16 | 18.0% |
| Food and Beverage | $19,094 | 707 | 6.4% |
| Travel and Lodging | $18,446 | 55 | 6.2% |
| Honoraria | $2,453 | 3 | 0.8% |
| Education | $513.60 | 8 | 0.2% |
| Gift | $26.70 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shionogi Inc | $79,992 | 94 | $0 (2024) |
| PFIZER INC. | $71,162 | 33 | $0 (2024) |
| AIMMUNE THERAPEUTICS, INC. | $52,453 | 37 | $0 (2024) |
| ViiV Healthcare Company | $45,728 | 256 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $36,813 | 72 | $0 (2024) |
| TETRAPHASE PHARMACEUTICALS, INC. | $4,587 | 21 | $0 (2020) |
| Gilead Sciences, Inc. | $1,010 | 42 | $0 (2024) |
| Insmed, Inc. | $961.24 | 44 | $0 (2024) |
| Merck Sharp & Dohme LLC | $883.07 | 44 | $0 (2024) |
| Astellas Pharma US Inc | $823.54 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $108,914 | 202 | AIMMUNE THERAPEUTICS, INC. ($52,393) |
| 2023 | $95,306 | 180 | PFIZER INC. ($46,986) |
| 2022 | $41,707 | 165 | Shionogi Inc ($18,541) |
| 2021 | $21,619 | 99 | ViiV Healthcare Company ($9,001) |
| 2020 | $12,855 | 58 | ViiV Healthcare Company ($7,693) |
| 2019 | $17,507 | 124 | ViiV Healthcare Company ($9,307) |
| 2018 | $774.04 | 37 | Astellas Pharma US Inc ($147.31) |
| 2017 | $24.99 | 1 | Astellas Pharma US Inc ($24.99) |
All Payment Transactions
866 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: HIV | ||||||
| 12/24/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.22 | General |
| 12/17/2024 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | Cash or cash equivalent | $22.65 | General |
| Category: Infectious Disease | ||||||
| 12/16/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: HIV | ||||||
| 12/06/2024 | PFIZER INC. | PAXLOVID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,525.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: HIV | ||||||
| 12/05/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/27/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: GI | ||||||
| 11/22/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,700.00 | General |
| Category: ANTIBIOTIC | ||||||
| 11/19/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: HIV | ||||||
| 11/14/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $121.23 | General |
| Category: ANTIBIOTIC | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/12/2024 | PFIZER INC. | PAXLOVID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/12/2024 | PFIZER INC. | PAXLOVID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/11/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: ANTIFUNGALS | ||||||
| 11/08/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: HIV | ||||||
| 11/08/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: HIV | ||||||
| 11/07/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: ANTIBIOTIC | ||||||
| 11/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/04/2024 | PFIZER INC. | PAXLOVID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/31/2024 | PFIZER INC. | PAXLOVID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.24 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,532 | 17,158 | $1.7M | $511,662 |
| 2022 | 12 | 1,353 | 11,851 | $1.4M | $407,785 |
| 2021 | 14 | 1,231 | 6,979 | $1.0M | $290,045 |
| 2020 | 8 | 1,110 | 2,952 | $841,459 | $233,602 |
Total Patients
5,226
Total Services
38,940
Medicare Billing
$1.4M
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 143 | 13,500 | $668,250 | $247,568 | 37.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 255 | 1,103 | $318,680 | $103,122 | 32.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 263 | 776 | $156,752 | $48,238 | 30.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 233 | 268 | $146,328 | $36,742 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 178 | 420 | $117,180 | $33,080 | 28.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 86 | 339 | $133,566 | $16,910 | 12.7% |
| 36573 | Insertion of tube for infusion with imaging guidance and review by radiologist, patient 5 years or older | Office | 2023 | 20 | 21 | $25,725 | $5,948 | 23.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $17,010 | $4,519 | 26.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 25 | $9,425 | $3,262 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 67 | $12,395 | $3,212 | 25.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 153 | 289 | $17,051 | $2,915 | 17.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 22 | $8,184 | $2,275 | 27.8% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 21 | 23 | $6,969 | $1,915 | 27.5% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 38 | 190 | $7,790 | $1,209 | 15.5% |
| J1335 | Injection, ertapenem sodium, 500 mg | Office | 2023 | 13 | 75 | $5,925 | $748.36 | 12.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 95 | 8,220 | $406,890 | $140,727 | 34.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 232 | 1,085 | $313,565 | $88,427 | 28.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 273 | 805 | $162,610 | $45,609 | 28.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 202 | 243 | $132,678 | $38,064 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 165 | 446 | $124,434 | $35,278 | 28.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 64 | 380 | $149,720 | $20,521 | 13.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Office | 2022 | 24 | 139 | $40,171 | $11,378 | 28.3% |
| 36573 | Insertion of tube for infusion with imaging guidance and review by radiologist, patient 5 years or older | Office | 2022 | 18 | 23 | $28,175 | $7,551 | 26.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Office | 2022 | 20 | 85 | $17,170 | $4,874 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $17,589 | $4,529 | 25.8% |
About Uriel Sandkovsky, MD, MS
Uriel Sandkovsky, MD, MS is a Internal Medicine healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2009. The National Provider Identifier (NPI) number assigned to this provider is 1104060904.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Uriel Sandkovsky, MD, MS has received a total of $298,707 in payments from pharmaceutical and medical device companies, with $108,914 received in 2024. These payments were reported across 866 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($143,510).
As a Medicare-enrolled provider, Sandkovsky has provided services to 5,226 Medicare beneficiaries, totaling 38,940 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease, Infectious Disease
- Location Dallas, TX
- Active Since 04/23/2009
- Last Updated 06/05/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1104060904
Products in Payments
- PAXLOVID (Drug) $71,088
- Fetroja (Drug) $57,795
- ZENPEP (Drug) $52,276
- NUZYRA (Drug) $36,813
- DOVATO (Drug) $15,488
- CABENUVA (Biological) $6,565
- Xerava (Drug) $4,575
- Arikayce (Drug) $961.24
- Mytesi (Drug) $445.21
- APRETUDE (Biological) $431.70
- PIFELTRO (Drug) $362.17
- RUKOBIA (Drug) $311.00
- CRESEMBA (Drug) $282.52
- Vibativ (Drug) $265.89
- SEROSTIM (Drug) $263.92
- SYMTUZA (Drug) $201.44
- XERAVA (Drug) $188.01
- PREZCOBIX (Drug) $180.48
- VOWST (Biological) $177.19
- REBYOTA (Biological) $166.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dallas
Andrew Whiteley
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Biff Palmer, Md, MD
Internal Medicine — Payments: $980,569
Internal Medicine $980,569
Dr. Robert Gottlieb, M.d. Ph.d, M.D. PH.D
Internal Medicine — Payments: $832,284
Internal Medicine $832,284
Dr. Ronan Kelly, Md, MD
Internal Medicine — Payments: $813,092
Internal Medicine $813,092
Dr. Gates Colbert, M.d, M.D
Internal Medicine — Payments: $801,349
Internal Medicine $801,349
Dr. Zoran Kurepa, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $743,379
Internal Medicine $743,379